MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott
Read Original Source
MiniMed logo Agreement builds on the companies’ ongoing partnership to expand choice and simplify diabetes management NORTHRIDGE, Calif., June 3, 2026 /PRNewswire/ -- MiniMed (NASDAQ: MMED), a global leader in diabetes technology, today announced an expanded agreement with Abbott to collaborate on commercializing dual glucose-ketone sensors designed to integrate exclusively with MiniMed smart dosing systems.
AI Summary
Main Idea: MiniMed said it is expanding its sensor lineup with Abbott-made dual glucose-ketone sensors that will work with its smart dosing systems to help detect dangerous ketone rises earlier.
Key Points:
- The new sensors are designed to track both glucose and ketones continuously in one device.
- MiniMed says earlier ketone alerts could help lower the risk of diabetic ketoacidosis, or DKA.
- The agreement builds on the companies’ existing partnership and gives MiniMed users more options across its insulin delivery products.
- The sensors are not yet cleared for sale in the U.S., and the companies said more regulatory and launch updates are expected soon.
Impact on the People
Negative Impact
Abbott’s dual glucose-ketone sensors are not yet cleared or sold in the US, so families may wait before any benefit arrives.
Positive Impact
MiniMed’s plan could give people with diabetes earlier warnings of rising ketones and may help prevent costly, life-threatening DKA episodes.
How did each entity affect people?
Rate how each entity in this article affected the American people.
Candidate Entities9 candidates · 5 weighted vote min · 70% decision
- AbbottcompanyPrimaryEvaluated
Key partner company whose dual glucose-ketone sensors are the subject of the agreement.
Include 0 (0%)Ignore 0 (0%)5 to threshold - MiniMedcompanyPrimaryEvaluated
Primary company announcing the expanded agreement and the central actor in the article.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Abbott dual glucose-ketone systembrand / productMajorAI selected
New sensor system at the center of the commercial and regulatory update.
Include 0 (0%)Ignore 0 (0%)5 to threshold - MiniMed Smart Dosing Systemsbrand / productMajorAI selected
Core MiniMed platform that the new sensors are designed to integrate with.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Que DallarapersonMajorAI selected
Named chief executive officer quoted on MiniMed’s strategy and the partnership.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Food and Drug Administrationgovernment agency or bodyContextCandidate
Mentioned as the U.S. regulator reviewing the dual glucose-ketone system.
Include 0 (0%)Ignore 0 (0%)5 to threshold - Instinct sensorbrand / productContextCandidate
Existing Abbott-made sensor cited as the basis for the expanded partnership.
Include 0 (0%)Ignore 0 (0%)5 to threshold
Comments 0
Comments here are the same thread shown when this article appears in The Pulse.
No comments on this article yet.
Sign in to comment